6,7-Dihydroxyisoindolin-1-one and 7,8-Dihydroxy-3,4-Dihydroisoquinolin- 1(2H)-one Based HIV-1 Integrase Inhibitors

E-ISSN： 1873-4294|16|4|435-440

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.16, Iss.4, 2016-02, pp. : 435-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Closely Related Antiretroviral Agents as Inhibitors of Two HIV-1 Enzymes, Ribonuclease H and Integrase: “Killing Two Birds with One Stone”

Current Pharmaceutical Design, Vol. 10, Iss. 30, 2004-11 ,pp. : 3713-3723

Bentham Science Publishers

Access to resources Recommend Favorite

Dipyrimidine-based inhibitors of HIV-1 integrase

By Neamati Nouri

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 2, 2003-02 ,pp. : 289-292

Informa Healthcare

Access to resources Recommend Favorite

3-Hydroxy-6,7-dihydropyrimido[2,1-c][1,4]oxazin-4(9H)-ones as new HIV-1 integrase inhibitors WO2011046873 A1

By Cotelle Philippe

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 11, 2011-11 ,pp. : 1799-1804

Informa Healthcare

Access to resources Recommend Favorite

Quinoline, Coumarin and Other Heterocyclic Analogs Based HIV-1 Integrase Inhibitors

Current Drug Discovery Technologies, Vol. 15, Iss. 1, 2018-04 ,pp. : 2-19

Bentham Science Publishers

Access to resources Recommend Favorite

HIV-1 Integrase Inhibitors: An Emerging Clinical Reality

By Dayam Raveendra Al-Mawsawi Laith Q. Neamati Nouri

Drugs in R&D, Vol. 8, Iss. 3, 2007-01 ,pp. : 155-168

Adis International

Access to resources Recommend Favorite